Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells
about
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomamiRNA dysregulation in cancer: towards a mechanistic understandingmiR-331-3p regulates expression of neuropilin-2 in glioblastoma.Biological Relevance and Therapeutic Potential of the Hypusine Modification System.The translation factor eIF5A and human cancer.Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs.MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionCellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.MicroRNA Changes in Firefighters.Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma
P2860
Q26784412-0ACC41EC-DCD2-461B-A93C-5BB4B3596C20Q27026420-452B3C4D-F1B7-4D82-96B3-90190E2F6E3BQ35021427-111979BB-0DEA-40DD-87BE-1A7EE4405BB2Q35883784-398DACBC-92B3-43BC-8EEF-C8B07C80357BQ36519353-F9B502D9-D4CC-4C2F-9974-EF67862E5BF9Q36545975-54A66997-24F8-467C-A91B-648C22BDE1D9Q36619906-F681B2F4-F043-47C2-8671-395FDED2D433Q37210229-A4234F86-46B7-40E1-82DF-8C35B26A73B4Q38881007-D8413808-13EC-4EE6-88C0-3F2E6EE7F478Q38995250-1A298F03-BCB4-41AF-923F-A37913B71737Q41549459-F4343A8E-E8B3-4B0D-9568-3DCC90DF99DBQ42251412-820C40B9-4B59-49C5-933F-30AFFA3FDE70Q47258537-28D19864-DE14-4554-9656-6ACD4F6FF828Q49712575-0E937F7B-A69A-497C-ADEE-E068421F6E7DQ53531177-3750875C-B250-41CA-A828-211764CDA2ADQ53628631-EAF6F4D3-0124-45E6-9725-BFEE02744D1BQ58726258-97114FB0-C906-4960-A585-C74563457FF6
P2860
Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Regulation of expression of de ...... 42-5p in prostate cancer cells
@ast
Regulation of expression of de ...... 42-5p in prostate cancer cells
@en
type
label
Regulation of expression of de ...... 42-5p in prostate cancer cells
@ast
Regulation of expression of de ...... 42-5p in prostate cancer cells
@en
prefLabel
Regulation of expression of de ...... 42-5p in prostate cancer cells
@ast
Regulation of expression of de ...... 42-5p in prostate cancer cells
@en
P2093
P2860
P356
P1476
Regulation of expression of de ...... 42-5p in prostate cancer cells
@en
P2093
Andrew Barker
Keith M Giles
Michael R Epis
Peter J Leedman
Ronald J Cohen
P2860
P304
35251-35259
P356
10.1074/JBC.M112.374686
P407
P577
2012-08-20T00:00:00Z